Product NDC 61314-0143

3 indexed presentations under this Product NDC family.

Reference only for licensed healthcare facilities. These listings support NDC-level identification and quote review, and do not imply current stock, manufacturer sponsorship, or direct purchasing status. Review package-specific NDC rows, compare configurations, and request a quote review when needed.

Need a Product Not Listed?

Submit a quote review for unlisted NDCs, item codes, or alternate product presentations.

Drug Search | Request a Quote Review

Family context

Product NDC 61314-0143 groups closely related presentations under the same catalog family, giving healthcare teams a clearer path for comparing packaging and alternate NDC rows before a quote review is requested.

  • Family size: 3 indexed presentations.
  • Generic family: Brimonidine Tartrate.
  • Primary dosage form: Solution.
  • Common strength: 2 mg / mL.

What changes inside this family

Use the family page to compare formats, then click into the NDC detail page that lists the package your team needs.

  • Manufacturers shown: Sandoz Inc.
  • Dosage forms shown: Solution.
  • Package quantities: 1 Bottle.

Manufacturer identifiers

Manufacturer information is shown for product identification only.

Official family references

Use official family-level references to verify labeling context while comparing the child NDC presentations shown on this page.

Showing page 1 of 1
Brimonidine Tartrate 2 mg / mL Solution 10 mL61314-0143-102 mg / mLSolution1 Bottle
Brimonidine Tartrate 2 mg / mL Solution 15 mL61314-0143-152 mg / mLSolution1 Bottle
Brimonidine Tartrate 2 mg / mL Solution 5 mL61314-0143-052 mg / mLSolution1 Bottle

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.